Khalid, S; Calderon-Larrañaga, S; Hawley, S; Ali, MS; Judge, A; Arden, N; van Staa, T; Cooper, C; Javaid, MK; Prieto-Alhambra, D; (2018) Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. Clinical epidemiology, 10. pp. 1417-1431. ISSN 1179-1349 DOI: https://doi.org/10.2147/CLEP.S164112

Losada, E; Soldevila, B; Ali, MS; Martínez-Laguna, D; Nogués, X; Puig-Domingo, M; Díez-Pérez, A; Mauricio, D; Prieto-Alhambra, D; (2018) Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study. Osteoporosis international. ISSN 0937-941X DOI: https://doi.org/10.1007/s00198-018-4581-y Full text not available from this repository.

Yuan, H; Ali, MS; Brouwer, ES; Girman, CJ; Guo, JJ; Lund, JL; Patorno, E; Slaughter, JL; Wen, X; Bennett, D; +1 more... ISPE Comparative Effectiveness Research Special Interest Group; (2018) Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG). Clinical pharmacology and therapeutics. ISSN 0009-9236 DOI: https://doi.org/10.1002/cpt.1086 Full text not available from this repository.